These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 1388653)

  • 1. Human T-cell activation deficiencies.
    Arnaiz-Villena A; Timón M; Rodríguez-Gallego C; Pérez-Blas M; Corell A; Martín-Villa JM; Regueiro JR
    Immunol Today; 1992 Jul; 13(7):259-65. PubMed ID: 1388653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ADA and PNP deficiencies: how it all began.
    Giblett ER
    Ann N Y Acad Sci; 1985; 451():1-8. PubMed ID: 3935025
    [No Abstract]   [Full Text] [Related]  

  • 3. Inherited enzyme deficiencies and immunodeficiency: adenosine deaminase (ADA) and purine nucleoside phosphorylase (PNP) deficiencies.
    Hirschhorn R
    Clin Immunol Immunopathol; 1986 Jul; 40(1):157-65. PubMed ID: 3087666
    [No Abstract]   [Full Text] [Related]  

  • 4. Genetic deficiencies of adenosine deaminase and purine nucleoside phosphorylase: overview, genetic heterogeneity and therapy.
    Hirschhorn R
    Birth Defects Orig Artic Ser; 1983; 19(3):73-81. PubMed ID: 6418227
    [No Abstract]   [Full Text] [Related]  

  • 5. [Congenital immunodeficiency syndrome with adenosine deaminase and purine nucleoside phosphorylase deficiencies (1)].
    Sakura N; Usui T; Ito K
    Nihon Rinsho; 1977 Jul; 35(7):2397-403. PubMed ID: 411963
    [No Abstract]   [Full Text] [Related]  

  • 6. Coupling of T-cell activation with T-cell receptor assembly.
    Terhorst C; Exley M; Franco R; Hall C; Kang J; Mueller B; Sancho J; She J; Wileman T
    Year Immunol; 1993; 7():1-24. PubMed ID: 8372498
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunodeficiency secondary to adenosine deaminase deficiency and purine nucleoside phosphorylation deficiency.
    Carson DA; Carrera CJ
    Semin Hematol; 1990 Jul; 27(3):260-9. PubMed ID: 2115692
    [No Abstract]   [Full Text] [Related]  

  • 8. Genetic deficiencies of adenosine deaminase and purine nucleoside phosphorylase and their implications for therapy of leukemias.
    Hirschhorn R; Ratech H
    Curr Top Hematol; 1983; 4():1-35. PubMed ID: 6413135
    [No Abstract]   [Full Text] [Related]  

  • 9. Possible metabolic basis for the different immunodeficient states associated with genetic deficiencies of adenosine deaminase and purine nucleoside phosphorylase.
    Carson DA; Wasson DB; Lakow E; Kamatani N
    Proc Natl Acad Sci U S A; 1982 Jun; 79(12):3848-52. PubMed ID: 6808516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymphocyte enzyme deficiencies and the metabolic basis of immunodeficiency disease.
    Polmar SH
    Clin Haematol; 1977 Jun; 6(2):423-38. PubMed ID: 410571
    [No Abstract]   [Full Text] [Related]  

  • 11. Immunodeficiencies associated with errors in purine metabolism.
    Edwards NL
    Med Clin North Am; 1985 May; 69(3):505-18. PubMed ID: 3925260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Primary immunodeficiencies: development and trends].
    Stoop JW; Zegers BJ
    Ned Tijdschr Geneeskd; 1986 Sep; 130(36):1592-5. PubMed ID: 3093903
    [No Abstract]   [Full Text] [Related]  

  • 13. Role of purines in lymphocyte function.
    Webster HK
    Asian Pac J Allergy Immunol; 1984 Dec; 2(2):311-17. PubMed ID: 6099730
    [No Abstract]   [Full Text] [Related]  

  • 14. Enzyme defects in purine metabolism and immunodeficiencies.
    Ito K
    Nihon Ketsueki Gakkai Zasshi; 1985 Dec; 48(8):1764-71. PubMed ID: 3939170
    [No Abstract]   [Full Text] [Related]  

  • 15. Development of immunity in human severe primary T cell deficiency following haploidentical bone marrow stem cell transplantation.
    Buckley RH; Schiff SE; Sampson HA; Schiff RI; Markert ML; Knutsen AP; Hershfield MS; Huang AT; Mickey GH; Ward FE
    J Immunol; 1986 Apr; 136(7):2398-407. PubMed ID: 2869085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenosine deaminase (ADA) and other enzyme abnormalities in immune deficiency states.
    Goldblum RM; Schmalstieg FC; Nelson JA; Mills GC
    Birth Defects Orig Artic Ser; 1978; 14(6A):73-84. PubMed ID: 215243
    [No Abstract]   [Full Text] [Related]  

  • 17. [Congenital immunodeficiency with adenosine deaminase and purine nucleoside phosphorylase deficiency].
    Sakura N; Usui T; Ito K
    Nihon Rinsho; 1977 Aug; 35(8):2564-80. PubMed ID: 411964
    [No Abstract]   [Full Text] [Related]  

  • 18. Molecules involved in T-cell costimulation.
    Jenkins MK; Johnson JG
    Curr Opin Immunol; 1993 Jun; 5(3):361-7. PubMed ID: 7688514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic defects and immunodeficiency disorders.
    Hirschhorn R
    N Engl J Med; 1983 Mar; 308(12):714-6. PubMed ID: 6402701
    [No Abstract]   [Full Text] [Related]  

  • 20. Adenosine deaminase and purine nucleoside phosphorylase deficiency: how they were discovered and what they may mean.
    Giblett ER
    Ciba Found Symp; 1978; (68):3-18. PubMed ID: 115664
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.